14 participants
A Phase 1 Study of AMV564 in Patients With Intermediate or High-Risk Myelodysplastic Syndromes
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-10-12
- Start Date:
- 2018-06-22
- Completion:
- 2020-07-31
Conditions
- Myelodysplastic Syndrome (MDS)
Interventions
- DRUG
No Results Yet